ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT

ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT

The invention provides an orodispersible solid pharmaceutical dosage unit having a weight between 30 and 1,000 mg, said dosage unit consisting of:0.1-25 wt. % of estetrol particles containing at least 80 wt. % of an estetrol component selected from estetrol, estetrol esters and combinations thereof;...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JASPART, Séverine Francine Isabelle, VAN DEN HEUVEL, Denny Johan Marijn, PLATTEEUW, Johannes Jan
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JASPART, Séverine Francine Isabelle
VAN DEN HEUVEL, Denny Johan Marijn
PLATTEEUW, Johannes Jan
description The invention provides an orodispersible solid pharmaceutical dosage unit having a weight between 30 and 1,000 mg, said dosage unit consisting of:0.1-25 wt. % of estetrol particles containing at least 80 wt. % of an estetrol component selected from estetrol, estetrol esters and combinations thereof; and75-99.9 wt. % of one or more pharmaceutically acceptable ingredients;the solid dosage unit comprising at least 100 μg of the estetrol component; and wherein the solid dosage unit can be obtained by a process comprising wet granulation of estetrol particles having a volume weighted average particle size of 2 μm to 50 μm.The solid dosage unit is easy to manufacture and perfectly suited for sublingual, buccal or sublabial administration.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024238209A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024238209A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024238209A13</originalsourceid><addsrcrecordid>eNrjZLD2D_J38QwOcA0K9nTycVVw8Q92dHdVCPXzDFFw9vcLcfT08_RzV3D0U3ANDnENCfL3AQr7Bvj7ufqF8DCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-NBgIwMjEyNjCyMDS0dDY-JUAQCqjCqN</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT</title><source>esp@cenet</source><creator>JASPART, Séverine Francine Isabelle ; VAN DEN HEUVEL, Denny Johan Marijn ; PLATTEEUW, Johannes Jan</creator><creatorcontrib>JASPART, Séverine Francine Isabelle ; VAN DEN HEUVEL, Denny Johan Marijn ; PLATTEEUW, Johannes Jan</creatorcontrib><description>The invention provides an orodispersible solid pharmaceutical dosage unit having a weight between 30 and 1,000 mg, said dosage unit consisting of:0.1-25 wt. % of estetrol particles containing at least 80 wt. % of an estetrol component selected from estetrol, estetrol esters and combinations thereof; and75-99.9 wt. % of one or more pharmaceutically acceptable ingredients;the solid dosage unit comprising at least 100 μg of the estetrol component; and wherein the solid dosage unit can be obtained by a process comprising wet granulation of estetrol particles having a volume weighted average particle size of 2 μm to 50 μm.The solid dosage unit is easy to manufacture and perfectly suited for sublingual, buccal or sublabial administration.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240718&amp;DB=EPODOC&amp;CC=US&amp;NR=2024238209A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240718&amp;DB=EPODOC&amp;CC=US&amp;NR=2024238209A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JASPART, Séverine Francine Isabelle</creatorcontrib><creatorcontrib>VAN DEN HEUVEL, Denny Johan Marijn</creatorcontrib><creatorcontrib>PLATTEEUW, Johannes Jan</creatorcontrib><title>ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT</title><description>The invention provides an orodispersible solid pharmaceutical dosage unit having a weight between 30 and 1,000 mg, said dosage unit consisting of:0.1-25 wt. % of estetrol particles containing at least 80 wt. % of an estetrol component selected from estetrol, estetrol esters and combinations thereof; and75-99.9 wt. % of one or more pharmaceutically acceptable ingredients;the solid dosage unit comprising at least 100 μg of the estetrol component; and wherein the solid dosage unit can be obtained by a process comprising wet granulation of estetrol particles having a volume weighted average particle size of 2 μm to 50 μm.The solid dosage unit is easy to manufacture and perfectly suited for sublingual, buccal or sublabial administration.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD2D_J38QwOcA0K9nTycVVw8Q92dHdVCPXzDFFw9vcLcfT08_RzV3D0U3ANDnENCfL3AQr7Bvj7ufqF8DCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-NBgIwMjEyNjCyMDS0dDY-JUAQCqjCqN</recordid><startdate>20240718</startdate><enddate>20240718</enddate><creator>JASPART, Séverine Francine Isabelle</creator><creator>VAN DEN HEUVEL, Denny Johan Marijn</creator><creator>PLATTEEUW, Johannes Jan</creator><scope>EVB</scope></search><sort><creationdate>20240718</creationdate><title>ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT</title><author>JASPART, Séverine Francine Isabelle ; VAN DEN HEUVEL, Denny Johan Marijn ; PLATTEEUW, Johannes Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024238209A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JASPART, Séverine Francine Isabelle</creatorcontrib><creatorcontrib>VAN DEN HEUVEL, Denny Johan Marijn</creatorcontrib><creatorcontrib>PLATTEEUW, Johannes Jan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JASPART, Séverine Francine Isabelle</au><au>VAN DEN HEUVEL, Denny Johan Marijn</au><au>PLATTEEUW, Johannes Jan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT</title><date>2024-07-18</date><risdate>2024</risdate><abstract>The invention provides an orodispersible solid pharmaceutical dosage unit having a weight between 30 and 1,000 mg, said dosage unit consisting of:0.1-25 wt. % of estetrol particles containing at least 80 wt. % of an estetrol component selected from estetrol, estetrol esters and combinations thereof; and75-99.9 wt. % of one or more pharmaceutically acceptable ingredients;the solid dosage unit comprising at least 100 μg of the estetrol component; and wherein the solid dosage unit can be obtained by a process comprising wet granulation of estetrol particles having a volume weighted average particle size of 2 μm to 50 μm.The solid dosage unit is easy to manufacture and perfectly suited for sublingual, buccal or sublabial administration.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2024238209A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T09%3A00%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JASPART,%20S%C3%A9verine%20Francine%20Isabelle&rft.date=2024-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024238209A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true